Stats

Premises: 1. Reproduced fixed252-high/1.5-volume breakout, separated21 sessions, next-open entry,20-session exit with vectorbt:30USD stock allocation per entry on1000USD test account,10bp fee and10bp slippage per side. Train2016–24; known chronological holdout2025–Sep18,2026. 2. HALO train+.49139%,DD.96270%,win50%,N14; holdout-.468923%,DD1.254913%,win33.333%,N3. TH train+.81828%,DD.71195%,win50%,N2; holdout+1.159881%,DD.469995%,win50%,N2. 50bp slippage stress holdouts-.53919/+1.10714%.10/20/30-session and cost sweeps recorded without choosing best holdout.3 CLI252lookback/2500days/5%stop/15%target HALO+15.1221%,DD9.51497%,win40.625%,N32;TH-7.91524%,DD22.61577%,win30.769%,N26, different exit/signal policy diagnostic only.4 Five approximate matching historical calls: two TH series absent, two HALO entry marks over30USD, remainingHALO missing required entryday. Zero complete affordable executable paths; absent bars are unknown, not zero returns. Conclusion: stock control is reproducible but does not validate option returns or15-minute stops. Holdout has been examined in earlier runs and is not a new independent out-of-sample test. Source https://runway.adityaperswal.workers.dev/data/stock-bars and /data/option-bars ; scripts research/study.py,models.py,history.py. No trade authorized by this stock proxy.

Premises: 1. Current HALO volume ratio6.93064 accompanies September17 convertible pricing; the issuer warns that hedge activity may affect price around issuance. 2. A primary SEC exhibit confirms another convertible pricing on February24,2021:700m at.25%, plus105m option. That date appears in the frozen breakout sample with10.57398 volume ratio and next-open20-session return-17.99684%. 3. One classified financing episode is not a six-event financing distribution and does not prove dealer causation. Conclusion: keep the full17-event breakout sample, but do not interpret elevated volume plus price strength as independent fundamental votes. Earlier momentum/SMA correlations .885/.898 remain inherited evidence, not recomputed today. A counterexample has weakened the organic-demand interpretation without removing the technical signal. Sources https://www.sec.gov/Archives/edgar/data/1159036/000119312521055596/d110113dex991.htm ; https://runway.adityaperswal.workers.dev/data/stock-bars ; current issuer pricing release recorded30218. Need actual post-financing persistence or disclosed paid demand to strengthen that interpretation.

Premises: 1. September 18 HALO close112.45 exceeds prior252-session high111.15 with volume6.93064 times prior20 mean; TH21.19 exceeds20.85 with volume2.41955. 2. October16 C130/C27 are active American contracts with100 multipliers, but both have NULL open interest. The3 and13 OI figures in the prior summary belonged to nearer C125/C26. 3. Indicative bid/ask0/.23 and.07/.18 imply liquidation markdowns100%/61.11%; they are modified quotes, not actual NBBO. If actual bid were.07, buyingTH at.13 would place its.065 stop below that bid; at.18 its.09 stop is above it. This is an algebraic threshold, not a fill forecast. 4. HALO C125 ask.48 and TH C26 ask.52 exceed30-dollar cap, despite TH C26 last trade.19. Conclusion: preserve gross-qualified watch, refresh actual attainable price, and verify stop mark before execution; never buy from stale close or infer zero OI from null. Remote stop-price convention could not be verified from local client source, so immediate-stop claims remain conditional. Sources https://runway.adityaperswal.workers.dev/data/stock-bars ; /data/option-chain/HALO?feed=indicative ; /data/option-chain/TH?feed=indicative ; https://docs.alpaca.markets/us/docs/historical-option-data .

Premises:1 HALOSep17issuerpricedconvertible/cappedcalls andoldnote repurchases; THSep10issuercompletedsecondary/concurrentrepurchase.2 Counterpartypositions/hedgefractionsnotreported. Firstorder: refinancingcreatescash/debtanddealerhedging,THmovesownershipwhileconsumingcorporatecash. Secondorder: shortcover/hedgebuyingmayliftspotandvolume withoutincrementalroyalty/customerorders; moredistributedTHownershipmaychangeliquidity. Thirdorder: aftertransactionflowends,valuationmustbesupportedbypaidroyaltiesorprofitablecontractconversion,orbreakoutcanreverse. Whobenefits: HALOgains~460mresidualcash/maturityextension at~16.92madditionalannualcoupon; THsellingsponsorsmonetizestakes;dealers earnfees. Strongcountercaseisnewlong-termownersandorganicgrowth sustainingtrend; noobservedhedgerpositionprovesdirection. Conclusionwatch,notnewshortorautomaticcall; HALOSep22expectedconditionalsettlementneedsprimaryreceipt,notinventedclinicalcatalyst. Sources: HALOpricing https://ir.halozyme.com/news/news-details/2026/Halozyme-Therapeutics-Inc--Announces-Pricing-of-Upsized-Private-Offering-of-1-3-Billion-of-Convertible-Senior-Notes-due-2033/default.aspx ; THclosing https://investors.targethospitality.com/news/news-details/2026/Target-Hospitality-Announces-Closing-of-Upsized-Secondary-Offering-and-Concurrent-Stock-Repurchase-and-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares/default.aspx . Factsendatdisclosedterms;flowdirectionsconditionalinferences.

Premises:1 Fixedprior252high+1.5volume,21sessionseparation,nextopenentry reproducesHALON17medianabs10.5263/P8017.2367%;THN4median27.3899/P8044.3186%.2 Sep18S112.45/21.19 Oct16C130.23/C27.18 imply15.8115/28.2681%moves, P80pay1.83266/3.58112 =>7.968/19.895x;bothtailpassbutmedianfail.3 LeaveoneoutHALOmultiple0–11.685,TH3.278–21.58;10dayboth0;30day4.940/17.593.4 HALO pre2025N14P80mappedcall0,known2025+N3multiple37.245;positive-signedP80only9.4523%=>call0,whereasabsolutetailtranslatesbothdirections. THN2train/N2testtailpasses butnotpreciselyestimated. Conclusion: mandatedgrosspass isrealcalculation,notrobustwinprobability. Do notraiseconfidenceorusehistoricalP80as80%successrate;singlecontractsremainresearchwatchforauthorizedsession. NoextraLOOgateinsertedintomandate; reportmodelriskandsizingimpact. These arecurrent-strikeintrinsicscenarios,notoptionreturns;20sessionsalignSep21–Oct16 assumingunchangedentryspot. Counterexampleto stationarity: HALO2020+34.19%vs2025-23.33%,currentfinancinghedgesunclassified. Source https://runway.adityaperswal.workers.dev/data/stock-bars and /data/option-chain/HALO?feed=indicative andTH. Rowsrecordedthisrun; currenteventunfinishedexcluded.

Premises:1 Sep17 HALO priced1.3bn1.5%notes, expectedSep22conditionalclose;1275mnet less162.5mcappedcalls and652.5mold-note cashrepurchases leaves460m,not1.3bnfreecash. Grossprincipal increases928.3m;annualcouponincrement16.92075m beforeotherdebtchanges.2 Issuer explicitly flags hedge purchases/old-note unwind aroundpricing; actualfractionofSep18volume unknown.3 THSep10secondary16.1mshares at18.50 producednocorporateproceeds;companyrepurchased1.693599msharesusingcashandABL. Conclusion: breakout eligibility persists,butvolume cannotbe countedasanindependentvoteoforganiccustomeracceleration. Strongcountercase: sustainedroyaltygrowth/contractconversion stilldrivetrend afterhedges; currentdata do notseparatecauses. Start100cash/1000equity;goalqualifiedsmalllongoption;bindingconstraint executableaffordablepremium andforecasttransportability. Noexactfutureearningsdateinvented. Sources https://ir.halozyme.com/news/news-details/2026/Halozyme-Therapeutics-Inc--Announces-Pricing-of-Upsized-Private-Offering-of-1-3-Billion-of-Convertible-Senior-Notes-due-2033/default.aspx and https://investors.targethospitality.com/news/news-details/2026/Target-Hospitality-Announces-Closing-of-Upsized-Secondary-Offering-and-Concurrent-Stock-Repurchase-and-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares/default.aspx . Settlementisfinancingmechanics,notdrugapproval; noautomaticpre-eventexit solelybecausepaymentsettlesSep22.

Start100USDfundcash/1000equity,ownpositions/orders0. Goal qualifiedconvexlongoptions; onepremium<=30,max4,total<=100. Premises:1 Broadscreen3584 of12836USsymbols yields8breakouts;newHALOOct16C130ask.23/P80pay1.83266=7.968x,N17 andTHOct16C27ask.18/P80pay3.58112=19.895x,N4 passgrossgate.2 Quotesindicative/closed;HALObid0andTHbid.07below.09half-askstop meanactualexecutionriskunresolved.3 Costedstockbacktests3594 andMC3596 are not actualoptionfills; sample/horizon/regimegapscanchangeodds.4 SFIXbestdatedearningsrejection28USD,21.831%hurdle>16.578%median,1.972xP80<4;HZO53cashdeal invalidatesstandalonehistory. Conclusion:noorders;100cashbecauseclosedauthorizedoptionsession, notbecauseallcandidatesfail. Mandatebreachcounter ofconsecutivetradingrunsdoesnotadvanceonclosedresearchrun. Monday09:50monitors427HALO/428TH refreshcapital/actualask/bid/underlying/eligibility, choosecheapestnearerlegwithin30ifpasses;singlecontractminimumgranularity,stop50%paid,targetdefendedP80atunchangedS1.83/3.58,horizonthroughOct16. ChangesinspotmustrecomputeP80,hurdleandhalfKelly,notmechanicallyreuselevels. RejectTHP18signedmappedpayoffsall0/halfKelly0;HALOputMCadverseprefercallwatch. Tail-onlybreakoutisnotabinaryevent; ifseparatedatedeventarisespriced>median,applypreeventexit. Fourpriorcollectorsretained,new283testedEND2/2scheduled480min96runs,remoteverificationpending;04UTCfollowupset. Lessons1107–9recorded. All1595completeUSsignalrows saved127observationbatches; international15andcrypto10bounded,noqualifyinghighbreaks. Gaps: recentSIPsnapshotaccess,lowIEXliquiditymisses,exhaustiveglobal/FDA/courtcoverage,CNXCmatchedhistory,historicalexecutableoptionbidasks. NoFUNDproposal; noownholding/closedtradeawaitslesson. Sources https://runway.adityaperswal.workers.dev/data/stock-bars ; /data/option-chain/HALO?feed=indicative andTH/SFIX; primarydatesandfinancials30001–4 andSFIXdateobservation.

Premises: hypotheticalSep21unchangedspot,20daily steps toOct16/25calendar days,NumPy30000paths/scenario seed92002. Bootstrap last252signedlogdailyreturns IID at.75/1/1.5scale, constantBSMIV calibrated toask and4%rate. HALOC130paid.23fitIV33.414%,P95paid.18IV38.114%,THC27paid.18IV68.513%;RV60HALO45.30/TH58.40%. Optionstop50%; modeledtargets filled no better than target, exitfriction.01/share+1USDroundtripfee. 3xpremium targets meanHALOC -8.90/-3.58/+1.78USD,THC -7.89/-4.71/+.02; apparent positive initialMC thatcreditedovershoots wasreplaced. P80targets independentlyderivedfrom3593 HALOC1.83 andTHC3.58 yieldmean -8.27/+1.42/+16.26 and-3.54/+7.28/+28.75;baseline targethits10.657%/4.557%,stops89.257%/91.873%,fullpremiumloss3.617%/5.847%. HALOPtarget1.93baseline -10.21USD,prefercallifquotedriskpass. These are uncalibrated regime-sensitive models, notconfidenceor executablebacktest; daily bars omit15minpath,quotesize/zero-bid,Americanfeatures andIVchanges. Stockreturns have positivehistoricaldrift: stationarity assumption canfail. Simulatedmarginalprofitdoesnotvalidate certainty. Keep wholepremium23/18 (<30 each),potential41total<100,max4; worstcase41+costs despitehalfpremiumstops. TerminalintrinsicKelly49.7/235.25USD unreliable; hardcap30 binds. Prospective singlecontracts are minimumgranularity, quarter30probe7.50unavailable. No ordersclosed; refreshcapital andactualquoteinentryrun. Source /data/stock-bars,/data/option-chain/HALO,TH?feed=indicative;30184–89.

Premises: HALO20daymomentum5.965%,distanceSMA50 17.141%,RV20 21.407%,volume6.931x;TH20.193%/21.967%/68.918%/2.420x. Last252session momentum-SMAcorrelation.8851HALO/.8977TH means these are mostly one trend observation. Separate trainOLS using signaldayknownfeatures predicts nextopen-to20close returns. HALO14train/3test MAE21.8884ppmomentum,20.7803SMA,20.6780RV,20.8975volume versusconstant20.7220pp; no convincing improvement. TH2train/2test perfect+/-1traincorrelations are mathematical artifacts of2points, testMAE102.215/39.993/51.890/30.510pp versusconstant28.842pp. Conclusion: no increasedconfidence orsize from correlated indicators or tiny regression. Currentbreakout qualifiesuniverse, mandatepayofftestedseparately; retain frozenfeatures forprospectiveobservation. Source https://runway.adityaperswal.workers.dev/data/stock-bars ; measured30182–83.

Premises: fixed252intradayhigh +1.5volume rule; vectorbt30USD stockperentry/1000book, nextopenentries,10bpfee+10bpslip eachside,20sessionexit,2016–24train/2025–Sep18,2026holdout. HALOtrain+.49139%,DD.96270%,win50%,N14;holdout-.468923%,DD1.254913%,win33.333%,N3. THtrain+.81828%,DD.71195%,win50%,N2;holdout+1.159881%,DD.469995%,win50%,N2. NEOholdout-.191897%,DD.43803%,win0%,N1. Sweep10/20/30sessions and50bpslip recorded30136–46;20sessionstressHALO-.53919%,TH+1.10714%. No bestholdoutselection. CLI lookback252days2500stop5target15:HALO+15.1221%/DD9.515/N32;TH-7.9152%/DD22.616/N26;NEO-6.0274%/DD15.971/N14. CLI usesdifferentexitpolicy, diagnostic only. Historicaloptionbars8illustrativeOCCqueries:2empty;HALOMay8,2025P60open.80oversized,Aug7,2026C100open3.93/P70.60oversized;Sep22,2025P65open.20,Oct3.70 isone usablemarkpath,notvalidatedbidask. HALOSep22C90missing;THMar12C12.5empty andMay12C15missing (May11C15price2.1implies wrongmoneyness fromearlierunadjustedspotassumption, noteligiblecomparison). Thus no independentexecutableoptionbacktest established. Stockcontroldoesnotproveoptioncrush/theta/stopprofits; intrinsicmappingisa scenario. Eligiblegrossgate remains watch, withsinglewholecontractlimit onlyafterfreshdata/sizinginentrysession. Source https://runway.adityaperswal.workers.dev/data/stock-bars ; /data/option-bars . No trade this researchrun.

Premises:1 Fixed volume-backed252high rule in3584, histories2016–Sep18,2026; first signal per21sessions, buy nextopen/sell signal+20close. HALO17events medianabsolute10.5263%,P8017.2367%;TH4 median27.3899%,P8044.3186%;NEO10median4.6374%,P8010.6641%. 2 Sep18 indicative HALO112.45 Oct16C130ask.23 needs15.8115%,P80intrinsic1.83266=7.9681x;P95ask.18needs15.6781%,P801.93266=10.737x. TH21.19 Oct16C27ask.18needs28.2681%,P803.58112=19.8951x;P18ask.23passesabsolutegate but ALL4signedmappedputpayoffs0, halfKelly0: rejectput.3 HALOcall/put signed terminalwins2/17each; THcall2/4. MappedmeanintrinsicHALOC1.72258/P.68072,THC1.86638 after.02friction gridhalfKelly4.97%/3.915%/23.525% equity; these are uncalibrated scenario odds, not validated execution.4 IID20kbootstrap HALOmedian95CI2.9843–14.1961%,P8010.6159–23.3302%;THP8013.3238–48.6125%, sparseandunstable. Originalsignal-close estimatesHALOC12.808x/THC27.927x superseded bynextopen figures. NEO16put.18needs20.5424% andP80pay0, rejects. SFIX earnings frozenN10median16.578/P8031.414 atS2.84Oct16P2.5ask.28 still21.831%hurdle/1.972x, best dated-earningsrejection. Conclusion:HALO/THcall research-qualified grossP80 candidates for freshauthorizedRTH review; cash tonight because optionsclosed. THsample4is allseparatedepisodes underfixedfilter, do not manufacture6 bycountingoverlap. HALOtailnotmedianpass; breakout is signaldate not a scheduled binaryevent,20sessionhorizon distinct frommandatorypre-eventexit ifa separatecatalystemerges. Sources /data/stock-bars and /data/option-chain/HALO,TH,NEO?feed=indicative; events/figures30132–46. No historicalintrinsiclabelledactualoptionPnL.

Premises:1 HALO June30 filing H1OCF420.969m versus253.932m and231m cash/marketables; average mid-single-digit partner-sales royalty. Aug6 issuer Q2revenue481m/royalties307.7m; adjustedEPSguide8.65–9 implies12.49–13.0x at112.45. Recurring paid royalties support operating case, but milestones/patents/partner concentration and adjusted-vs-GAAP differences constrain valuation.2 TH Aug10 Q2revenue85.5m(+39%),netloss9m,adjEBITDA18.2m;H1OCF111m dominated by customeradvances.1.4bn multi-year awards/9000beds are not annual revenue;20000bed pipeline not contracts. Sep10secondary16.1mshares at18.50 proceeds tosellingholders, not corporatecash.3 NEO Jul28 Q2revenue202m(+11%),clinical187m(+14%),netincome2m includes11m debtgain,OCF20m. Aug26coverage adds thirdRaDaRindication,two morepending with no deadline.4 HZO Aug10agreed53cash versus52.56stock; Oct16C55 cannotpay from announcedconsideration, and prior standalonebreakouttails do not price dealbreaks. Validity: paid activity can support tails but does not prove directional probability. Countercases: HALO royalty setbacks;TH advances fundfuturecosts;NEO coveragewithoutprofitablevolumes;HZO competingbid/termination. Start100cash; goal small qualifiedlongoptions; bindingconstraints currentask<=.30 and actualhistoricalcomparablepayoff. No new datedeventinvented;HALO/TH considered under technicalbreakoutmandate. Sources observations30001–4; NEO https://ir.neogenomics.com/news-events/press-releases/detail/336/neogenomics-reports-second-quarter-2026-results and /detail/337/neogenomics-receives-medicare-coverage-for-radar-st-for-immunotherapy-treatment-response-monitoring . Exactcourtcalendar not verified, not prerequisite for breakout eligibility.

Premises:1 NasdaqTrader nasdaqlisted/otherlisted directories contain13221 non-test rows including one malformed symbol;12836 alphabetic/dotted symbols requested after preferred-format batch failures repaired.2 IEX snapshots12689,12420 with usable current/prior bars;1643 non-ETF names with price>=1 and reported dollar volume>=2m receive historical SIP bars.3 All1643 histories returned;1595 have253+bars. Sep18 close above prior252 intraday highs AND volume>=1.5prior20mean AND prior20 dollarvol>=2m yields8:HALO112.45/6.931x,NEO19.91/2.537,NTRA369.39/3.095,SMTC185/1.699,TH21.19/2.420,TWST166.99/1.825,HZO52.56/1.717,MPC424.89/3.965. Technical eligibility is not option edge. Source https://www.nasdaqtrader.com/dynamic/SymDir/nasdaqlisted.txt and otherlisted.txt; https://runway.adityaperswal.workers.dev/data/stock-snapshots?feed=iex ; /data/stock-bars SIP/all. Recent SIPsnapshots403, IEXpartial-volume screen may miss liquid names; stale IEX snapshots retained for broad history screening, only Sep18 full bars qualify.48 short histories not declared failures.15 selected international stocks/indexes show0close-high breaks; tencrypto majors0intraday-high+volume breaks using completedSep19. International selection is bounded, not exhaustive. OIG huge raw return/name mapping requires corporate-action audit, no trade from movers alone. This repairs prior narrow13-name coverage but does not establish exhaustive catalyst census.

Premises:1 SEC Sep17 announcement grants conditional temporary TSV/AMM relief, permissioned access, volume/symbol limits and issuer objection rights.2 It is already announced before Sep20 research, not a future dated event.3 No contract-level historical same-kind distribution or attributable token cash flow measured. Consequence chain: first, permitted venues can offer qualifying stock liquidity subject to conditions; second, incumbents face potential order-flow competition and integration demand; third, economics depend on actual migration, fees, compliance cost and issuer participation, with no necessary value transfer to UNI or any single network. Who benefits: participating venues/providers potentially, contingent on paid volume. Strong countercase is rapid migration; evidence needed is actual venue notices/volume and retained fees. Conclusion watch primary adoption, do not turn a weekend repeat headline into an unpriced scheduled catalyst. Source https://www.sec.gov/newsroom/press-releases/2026-90-sec-issues-innovation-exemption-facilitate-trading-tokenized-nms-stock-request-comment . Facts about scope/timing end before these conditional economic inferences.

Start state:100USDfundcash,1000account equity, no own trades/positions/orders confirmed query_trades. Goal: qualified convex-tail exposure. Binding constraint is attainable whole-contract premium<=30 and mandate payoff, not fundingdeadline. Premises:1 freshSFIXOct16P2.5ask.28/S2.84 needs21.830986% versusN10median16.578014%; P80payoff.552156=1.971985x<4. Best rejectedticket remainsSFIX,28USDpremium. 2 BBbest.176778x andLW inclusive11eventbest.931230x fail; all130affordable expiryeligiblelegs fail. 3 Thirteen-name close-based52week screen0passes. 4 FDAOct1meeting isstrainselection, not a mappedcompanyapproval; noedge inferred. Conclusion:noorders,100cash; closedresearchrun is not a missedauthorizedentry. No holdings, so no stops/targets reset or closedtradelessons due. Watchlist strongestcountercases3552/3553, inclusiveeventstat3554, stockbacktest3557, indicators3558, exitMC3559 recorded. A positiveheld-eventMC/halfKelly cannot substitute for a failedgate or incompatiblepre-eventexit. At09:50/12:30 refreshcapital/date/quote, use signedodds/halfKelly, wholeqty,fullpremium<=30,total100,max4,stop50%actualpaid,target3x ordefendedP80,expiry>=7daysafterevent; holdthroughonlyifpricedmove<=median. ExistingSFIX404/405 andBB407/408 preserved; LW422/423 added, job280testedEND2/2 andscheduled96x480min. ExactOct2024newsminute, historicaloptionexecution, exhaustiveFDA/court/global/cryptooptioncensus remain gaps; no claim wholemarket hasnoedge. Sources https://runway.adityaperswal.workers.dev/data/option-chain/SFIX?feed=indicative andBB/LW; issuerdates inobservations29824 and finalquotereceipts. No FUND proposal.

Premises: S46.67 K37.5 paid.23, indicativeIV55.94%, N11 empirical signed reactions3554. NumPy50k paths/scenario, seed92000,20businesssteps Sep21–Oct16, eventstep12 Oct6; zero-drift GBM26/40/60% ordinaryvol, empiricalevent replaces dailyreturn. BSM put floored intrinsic,4% rate assumption, preIV55.94%,postIVscenario; initialmodel.23647 vsask.23. Daily stop.115,target.69, exit .01/share friction plus1USD roundtripfee. Hypothetical hold-through means+3.27/+8.81/+7.67USD, targets4.83/11.78/22.62%,but current20.14% hurdle exceeds10.02%median so this hold policy is outside mandate. Mandate-consistent forced Oct5 day11 exit means-13.81/-9.02/+.88USD, targets.556/7.006/20.698%. These uncalibrated daily marks omit American/dividend details and15-minute quote/liquidity risk. Full-premium loss remains possible despite half-premium stop. Separate empiricalterminalintrinsic after.02 friction:2/11wins, meanintrinsic.650308, grid halfKelly6.704% equity; it omits timevalue/path and uses same observed tails, so not live odds. It cannot override failedgate; actualsize0, future onepremium<=30,total100,max4. Crucial counterexample: higher price of a nearerstrike may passmedian when cheapenough; reprice rather than claim modelprofits at an impermissible hold. Sources https://runway.adityaperswal.workers.dev/data/option-chain/LW?feed=indicative ; stockbars and issuerOct6date29824.

Premises:11events with9training2024–25 and2heldout2026, pre-event features shiftedone day; dailySIP. Separate OLS regressions of signedclose reaction on momentum20,distanceSMA50,RV20,volume/prior20mean. HoldoutMAE7.40677/1.10737/5.50847/5.21764pp versusconstanttrainingmean4.88297pp. OnlydistanceSMA50 improves this tinyholdout. Trainingcorrelations-.098887/.146293/.070651/-.012508; fullsamplemomentum-SMAfeaturecorrelation.755875. Conclusion no reliable directionalprobability: ninepoints estimateeachintercept/slope and twooutcomes cannot validate selectedfeature. Counterexample persistentregime might produce real predictability; next prospective event must test frozenmodel withoutrefit. Trend/volume indicators are correlated context, not independentvotes. Source https://runway.adityaperswal.workers.dev/data/stock-bars ; eventdateobservations29808–26.

Premises: 11-event calendar3554, Oct2024 usesOct2 with timing sensitivity retained. vectorbt,1000USD book,30USD stock exposure per event,10bp fees plus10bp slippage eachside. Enter close1/3/5sessions before reactionclose; exit reactionclose. Fixed T1 long train2024–25 return-1.90786%,DD2.00696%,win44.444%,N9;2026holdout return-.267331%,DD.285865%,win50%,N2. T1 short diagnostic train+1.69907%,holdout+.220306%,DD.036535%,win50%,N2; shorts unavailable under mandate. T3/T5 long holdouts-.101134/-.082821%; short+.053443/+.035056%, no bestholdoutselection. Lag3/5trainingN8 because Januaryentry falls outside trainingboundary. CLI breakout20,730days,5%stop/15%target returns25.933855%,DD7.50904%,win37.931%,29trades, buyhold-28.736159%; lacks independentholdout and explicitcost audit, so diagnostic only. Positive CLI or shortunderlying returns cannot establish longputtheta/crush or actual15minute optionexit profits. No live optionstrategy passed; no trade rests on proxy. Source https://runway.adityaperswal.workers.dev/data/stock-bars .

Premises: ten issuer earnings dates observed29808–17 plus October2024 sensitivity29826. Excluding ambiguous October produces N10 median13.153864%,P8021.271719%; including either Oct1 orOct2 reaction yields N11 median10.017371%,P8020.107527%. Do not remove small events because timing is uncertain. LW S46.67 Oct16P37.5 ask.23/bid.18 requires20.141418%; inclusiveP80intrinsic.2141828=.931230x versus4required (exclusion3.293526x alsofails). N11 training9median16.290357%,holdout2median4.882973%; IID50k bootstrap median95CI2.5712–20.1075%,P8010.0174–28.2374%. Broad uncertainty is not evidence of a pass. Fresh complete chains: LW40legs/6affordable eligible; SFIX60/19; BB532/105; zero passes among130affordable expiryeligible legs. SFIX Oct16P2.5 .28,S2.84 still21.830986%hurdle vs inheritedN10median16.578014%,P8031.413933%,1.971985x; BB Oct2P7 .20,S7.99 needs14.893617%vs inheritedN13median9.1152815%,P8012.832986%,.176778x. Sources https://runway.adityaperswal.workers.dev/data/option-chain/LW?feed=indicative and analogousSFIX/BB; dailybars and issuerobservations. Figures describe strike-plus-premiumbreakeven, notATMimpliedmove; P80intrinsic notactualoptionEV. Conclusion reject quoted legs; executable spreads/timevalue and future regime remain uncertain.

Startstate: noownholdings; these are watchlist hypotheses. SFIXbear chain:1 retention/margindeterioration ->2 lesscash afterinventory/marketing ->3 weakerfundingflexibility andequityvalue. Strongcounterchain:1 clientrecovery ->2 acquisitioncostabsorption/cash ->3 rerating, hurtingputs. LWbear:1 customerpriceconcessions/underutilization ->2 lowercashmargin ->3 lessdeleveraging/equityvalue. Counterchain:1 capacitydiscipline ->2 cashreleased ->3 debtpaydown/valuationresilience. Who benefits: customersfromsupplierconcessions; creditorsfromcashretention; managementfromadjusted-performanceframing. Readthrough toapparel/frozenfood peers is conditionalonchannelmix, notautomatictrade. Facts end atobservations29827–28; allthree-stepchains are inferences withoutcalibratedprobabilities. Today's verified calendar/data audit changesresearchcoverage, not reportedoperatingfacts; noholdingstop/targettochange. Sources originalresults in29827–28 and https://investors.stitchfix.com/ ; https://investors.lambweston.com/ .

Premises: observations29827/29828 recheck primary historical results, not newweekendearnings. SFIX shows sequential client recovery and liquidity withoutdebt; these undermine a distress put. Lower margins and buybacks exceedingquarterFCF keep execution risk relevant. LW cash generation improved substantially as capex fell, while international profitability weakened. Neither adjustedearnings decline nor lowshareprice alone establishes futuretail direction. Counterexamples: stabilization could drive gains; renewedpricecompetition could overwhelm savings. Validity: conditionalcash-to-equitymechanism is coherent. Soundness: futurecash and marketexpectations remain unmeasured. No position or exit reset; both current tickets fail the independentpremium/payoffgate. Sources https://investors.stitchfix.com/news-events/press-releases/news-details/2026/Stitch-Fix-Announces-Third-Quarter-of-Fiscal-2026-Financial-Results/default.aspx ; https://news.lambweston.com/news-releases/news-release-details/lamb-weston-announces-q4-and-full-year-fiscal-2026-results .

Premises: Sep18 completed SIP adjusted daily bars, 931pername sinceJan2023; observations29778–90. Screen includes established most-active names, US-listed foreign issuers, biotech and crypto-linked equities. Every close is below prior252-session intradayhigh. LW46.67/high65.06,vol1.442x,SMA50 50.7544/SMA20046.0587,ATR20 1.398325,RV20 25.9098%,momentum20-12.7174%; SFIX2.84/high5.94,vol2.016x,BB7.99/high13.59. COIN194.25/high402.16,HOOD119.82/high153.8599,MSTR153.92/high365.21. Conclusion: highvolume and 20-day gains do not qualify a52weekbreakout. Counterexample intraday breakout/reversal may occur, but fixed completedclose criterion not met. No spotcrypto/equity substitute under longoption-onlymandate. Bounded thirteen-name screen, not whole-market exhaustion; most-active microcaps excluded pending liquidity/corporate-action verification. Source https://runway.adityaperswal.workers.dev/data/stock-bars ; snapshotselection https://runway.adityaperswal.workers.dev/data/most-actives .

Start state: $100 fund cash, $1000 account equity, zero own positions/orders/trades confirmed query_trades. Goal: participate in qualified convex tails. Binding constraint: attainable whole-contract premium <=$30 and measured payoff, not the operator's funding deadline. Premises: (1) SFIX Oct16P2.5 at unchanged indicative .28/S2.84 needs21.830986% versus N10 median16.578014%; P80 payoff .552156=1.971985x, so both gates fail. This remains best rejected ticket, $28 full premium. Source https://runway.adityaperswal.workers.dev/data/option-chain/SFIX?feed=indicative ; Sep23AMC issuer https://investors.stitchfix.com/news-events/press-releases/news-details/2026/Stitch-Fix-Announces-Date-for-Fourth-Quarter-and-Full-Fiscal-Year-2026-Financial-Results-and-Conference-Call/default.aspx . (2) CAG eleven-event study3513 gives median2.06441/P805.42133%; $23P14 needs8.98876%, P80zero; 0/68 affordable eligible legs pass. (3) ABVX financial-results sample unestablished; affordableP71 needs32.6733%; MLKN inherited cheapest$52 exceeds cap. (4) IONS September22 FDA premise obsolete after September3 approval, source29647. (5) No own due monitors or holdings; retired funds' overdue monitors not silently resolved. Conclusion: no orders, retain100cash; closed research run is not a missed authorized trading entry. Strong counterexample: fresh nearer cheap option passes. At unchanged spots SFIXP2.5 costed median ceiling .110816, BBP7.5 inherited .218311, CAGP15 .162345 after assumed.02 friction; these are research thresholds, not quotes. At09:50/12:30 refresh issuer status/quotes/capital, use honest signed odds and halfKelly, whole contracts premium<=30,total<=100,max4; stop50% actual option premium, target3x premium or defendedP80, expiry>=7days afterevent. Hold through only when priced move<=median; tail-only pass needs explicit pre-event exit. Negative stock proxies do not permanently veto a newly qualified tail. New calendar monitors417/418 and CAG419/420; SFIX404/405 andBB407/408 preserved. Job279 localEND3/3 tested, scheduled480min96runs; remote receipt pending. No exhaustive FDA/court/52week/crypto-option census, actual option holdout/15-minute execution unresolved. Analysis valid for retrieved candidates, not claim whole market has no edge.

Premises:11datedreactions3513;9training2024–25,2holdout2026. Four separateOLSwithintercept use preeventmomentum20,distanceSMA50,RV20,volume/prior20mean to predict signedclose reaction. Training correlations .2053/-.0398/.0261/.5814; testMAE1.6771/.7259/.4432/4.5208percentagepoints, versusconstanttrainingmean.4122pp. Momentum anddistanceSMA50 correlation.81084,notindependentvotes. Conclusionnoindicator improvesbaselineinthis tinyholdout; reject stackeddirectionalconfidence. Counterexampleotherregimesmaydiffer; no modelselectiononholdout andnocalibratedprobability. Currentpricebelowaverages alonecannot justifyputorchangefundsize. Source https://runway.adityaperswal.workers.dev/data/stock-bars and11primaryeventobservations.

Premises: 11 close-event reactions3513; S15.13,K14,indicativeask.23/IV.3516 fromchain. NumPy50k paths each,seed91908,20businessdaysSep21-Oct16,eventstep8Sep30; empiricalreaction replaces ordinaryreturn on eventday, otherdayszero-driftGBM22.5/35/50%annualvol. BSM put flooredintrinsic,preIV.3516/postIVscenario vol,r4%assumed;initialmodel.168158 differsask.23,so this is exit-policy sensitivity notfair-valueproof. Daily modeledstop.115,target.69,elseexpiry;exit.01/sharefriction+$1roundtrip. MeanPnL -12.3303/-6.1652/+.1245USD;target5.052/13.464/21.866%,stop93.924/85.970/78.006%;P05-23.2405/-20.4268/-21.2576USD. Uncalibrateddailyprices omitAmericanexercise/dividendboundary andactual15-minute liquidity; probabilities are model outputs, not live estimates. Empirical terminalintrinsic logutility grid halfKelly0 after.02friction. Conclusion size0 forfailedmandate; evenpositivehigh-volscenario doesnotrescueP80gate. Futurequalifyingticket fullpremium<=30, total<=100,max4;50%stop doesnot cap gaploss. Source https://runway.adityaperswal.workers.dev/data/stock-bars and option-chain/CAG?feed=indicative .